Log In
Print this Print this

IMM-124E (formerly Imm124-E)

  Manage Alerts
Collapse Summary General Information
Company Immuron Ltd.
DescriptionOral formulation of hyperimmune bovine colostrum powder
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationNon-alcoholic steatohepatitis (NASH)
Indication DetailsTreat non-alcoholic steatohepatitis (NASH; fatty liver disease)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today